Skip to main content
. Author manuscript; available in PMC: 2019 Jan 2.
Published in final edited form as: Clin Lung Cancer. 2014 Jan 1;15(3):202–206. doi: 10.1016/j.cllc.2013.12.009

Table 1:

Clinical and Tumor Characteristics of NSCLC Patients Diagnosed with Leptomeningeal Carcinomatosis.

Patient Characteristic Percent (Number/Total)
Number of Patients 30
Adenocarcinoma Histology 100% (30/30)
Women 67% (20/30)
Age (Mean) 58
Stage IV at NSCLC Diagnosis 73% (22/30)
Current or Former Smoker 30% (9/30)
LM Disease at Time of Metastatic Presentation 27% (8/30)
Diagnosis by MRI 97% (29/30)
Diagnosis by Lumbar Puncture 33% (10/30)
ECOG PS at LM Diagnosis
- ECOG PS 0–1 46% (14/30)
- ECOG PS ≥ 2 54% (16/30)
Neurologic Symptoms 70% (21/30)
Brain metastases
- Prior to LM Diagnosis 50% (11/22)
- At Diagnosis of LM 73% (22/30)
Race
- Asian 53% (16/30)
- White 37% (11/30)
- Hispanic 7% (2/30)
- Not Known 3% (1/30)